Genentech, Inc. - Product Pipeline Review – 2016 Growth, Future Direction and Operating Technology
Genentech, Inc. - Product Pipeline Review - 2016 Size and Share Published in 2016-02-24 Available for US$ 1500 at Researchmoz.us
Description
Global Markets Directs, Genentech, Inc. - Product Pipeline Review - 2016, provides an overview of the Genentech, Inc.s pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by Genentech, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Download Sample of this Report at: http://www.researchmoz.us/enquiry.php?type=S&repid=676810
Scope
- The report provides a snapshot of the pipeline therapeutic landscape of Genentech, Inc.
- The report provides overview of Genentech, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Genentech, Inc.s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Genentech, Inc.s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
- Evaluate Genentech, Inc.s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Genentech, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Genentech, Inc.s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Make an Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=676810
Table of Content
Table of Contents 2
List of Tables 5
List of Figures 5
Genentech, Inc. Snapshot 6
Genentech, Inc. Overview 6
Key Information 6
Key Facts 6
Genentech, Inc. - Research and Development Overview 7
Key Therapeutic Areas 7
Genentech, Inc. - Pipeline Review 12
Pipeline Products by Stage of Development 12
Pipeline Products - Monotherapy 13
Pipeline Products - Partnered Products 14
Pipeline Products - Out-Licensed Products 16
Genentech, Inc. - Pipeline Products Glance 18
Genentech, Inc. - Late Stage Pipeline Products 18
Genentech, Inc. - Clinical Stage Pipeline Products 19
Genentech, Inc. - Early Stage Pipeline Products 22
Genentech, Inc. - Drug Profiles 25
crenezumab 25
etrolizumab 27
lampalizumab 29
Browse All Pharmaceutical Market Research Reports at: http://www.researchmoz.us/pharmaceutical-market-reports-38.html
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.
Contact Us:
ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/